Neurofibromatosis Therapeutic Acceleration Program (NTAP) is dedicated to advancing treatment options for individuals with NF1 associated neurofibromas (cutaneous, plexiform and atypical).
In order to do this we:
- Identify the most promising opportunities to develop effective therapies
- Deliver the critical support, resources, and directives to develop these ideas and ensure successful follow-through
- Remove obstacles to ensure patients benefit from research advances as quickly as possible.
NTAP uses a highly collaborative approach that brings together patients, clinicians, researchers, industry, and government to determine where resources are most effectively deployed to produce meaningful treatments. Exceptional partners with innovative ideas are recruited to make these plans a reality, through both targeted programs and investigator-initiated proposals. NTAP invests in all areas of therapeutic discovery, always keeping the final goal of an effective therapy for a real patient at the center of the project goal.